Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report

por Olsen, T. Anders, Martini, Dylan J., Evans, Sean T., Goldman, Jamie M., Bilen, Mehmet Asim
Publicado 2021

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

por Olsen, T. Anders, Martini, Dylan J., Goyal, Subir, Liu, Yuan, Evans, Sean T., Magod, Benjamin, Brown, Jacqueline T., Yantorni, Lauren, Russler, Greta Anne, Caulfield, Sarah, Goldman, Jamie M., Harris, Wayne B., Kucuk, Omer, Carthon, Bradley C., Master, Viraj A., Nazha, Bassel, Bilen, Mehmet Asim
Publicado 2021

Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

por Martini, Dylan J., Olsen, T. Anders, Goyal, Subir, Liu, Yuan, Evans, Sean T., Magod, Benjamin, Brown, Jacqueline T., Yantorni, Lauren, Russler, Greta Anne, Caulfield, Sarah, Goldman, Jamie M., Nazha, Bassel, Kissick, Haydn T., Harris, Wayne B., Kucuk, Omer, Carthon, Bradley C., Master, Viraj A., Bilen, Mehmet Asim
Publicado 2021

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

por Martini, Dylan J., Olsen, T. Anders, Goyal, Subir, Liu, Yuan, Evans, Sean T., Hitron, Emilie Elise, Russler, Greta Anne, Yantorni, Lauren, Caulfield, Sarah, Brown, Jacqueline T., Goldman, Jamie M., Nazha, Bassel, Carthon, Bradley C., Harris, Wayne B., Kucuk, Omer, Master, Viraj A, Bilen, Mehmet Asim
Publicado 2022